We employed a murine monoclonal antibody (CH41) and a 2gtl 1 library of human cytomegalovirus (CMV) DNA fragments to map the gene for a viral protein, denoted infected cell protein (ICP) 22, to the HWLF1 open reading frame in the S component of the CMV genome (0.92 to 0-93 map units). By using antibody CH41 in immunofluorescence, immunoprecipitation and immunoblotting analyses, ICP22 was readily detected as a fl (delayed early) gene product during viral growth. The cellular localization of this protein was found to be nuclear by immunofluorescence analysis; however, it partitioned with the cytoplasm when cells were fractionated with non-ionic detergents. Analysis of cell-flee medium showed that a proportion of ICP22 was released from cells as a soluble protein at both early (24 h) and late (72 to 120 h) times in infection. The function of this protein which has such diverse characteristics remains unknown.
. Immunofluorescence analysis of CMV-infected human fibroblast cells with murine monoclonal antibody CH41. Infected cells were fixed with methanol at 24 (a), 48 (b) or 72 (c) h p.i. with 1 p.f.u, of CMV (AD169) per cell (Pereira et al., 1982) , incubated first with CH41 and then with a fluoresceinconjugated goat anti-mouse serum, and photographed. The properties of CH41 have been previously described (Pereira et al., 1982; Pereira & Hoffman, 1986) . 1987) which is not known to be exported. Here we report the mapping of a CMV fl gene to the HWLF1 reading frame in the S component of the CMV genome (Weston & BarreU, 1986) . Whereas immunofluorescence analysis indicated that this protein has a nuclear location, cell fractionation studies showed that the gene product was cytoplasmic with a proportion released from infected cells into the medium. Using methods we have previously described for the mapping of genes encoding the two major CMV DNA-binding proteins Kemble et al., 1987) , we used mouse monoclonal antibody in conjunction with a 2gtl 1 library of CMV D N A fragments to identify the protein and isolate a phage clone expressing the reactive epitope.
Immunofluorescence analysis with monoclonal antibody CH41 revealed a nuclear staining pattern in infected cells at both early and late times in infection (Fig. 1) , a pattern that was also observed when cells were treated from the time of infection with phosphonoacetate (100 ktg/ml). The pattern of nuclear fluorescence was uniform with occasional cells showing lighter cytoplasmic fluorescence, especially at later times [72 h post-infection (p.i.) ]. By immunoprecipitation (Pereira et al., 1982; Pereira & Hoffman, 1986) or immunoblot (Fig. 2) analysis, CH41 recognized a single protein species with an apparent Mr of approximately 76K, designated infected cell protein (ICP) 22 (Pereira & Hoffman, 1986) . These characteristics led to the suggestion that this protein might correspond to the abundantly expressed 'major immediate early' protein of CMV (Pereira & Hoffman, 1986 samples with an electrophoretic mobility similar to ICP22 resulted from spurious reactivity with biotinavidin reagents and is not observed in immunoprecipitates of ICP22 (Pereira & Hoffman, 1986) . Mr standards (x 10 -3) are indicated to the right of the panels. The mobility of ICP22 appears slightly greater in this gel than in previous analyses (Pereira & Hoffman, 1986) . HF cells were infected at an m.o.i, of 10p.f.u. CMV (Towne) per cell and radiolabeIled with [3sS]methionine (2001xCi/mI; Amersham) for 2 h at the indicated times as previously described (Geballe et al., 1986a, b) . Whole cell, nuclear and cytoplasmic fractions were prepared with a modification of previous methods (Geballe et al., 1986a, b) : cells were rinsed with 150mM-KC1, 1 rr~-EDTA and 10mM-EDTA and 10raM-potassium phosphate pH 7.5, and then a 25 cm 2 cell monolayer was collected in 0.5 ml 1% NP40, 1 deoxycholate, 1 mM-EDTA, 10 mM-potassium phosphate by rocking on ice.
(a) nuclear, ICP22 partitioned with the cytoplasm when cells were fractionated with non-ionic detergents (Fig. 2 ). We have not been able to detect [3H]glucosamine incorporation into immunoprecipitable ICP22 even after prolonged (48 h) labelling periods and biotinylated lectins known to recognize glycoconjugates did not bind to ICP22 (data not shown). By these criteria, ICP22 did not appear to be glycosylated. We screened 105 phage from a randomly generated 2gtl 1 library of CMV DNA fragments using previously published procedures Kemble et al., 1987) and purified a total of three recombinant phage immunoreactive with CH41 antibody. Each of these phage and one plasmid subclone (pON293), were used to probe blots of CMV DNA restriction fragments and all hybridized to a unique region with the S component of CMV strains Towne or AD169 (Fig. 3) . CMV (Towne) EcoRI C, HindlII S, and XbaI G fragments hybridized to these probes while CMV (AD169) EcoRI C, HindlII W and XbaI J were found to hybridize (Fig. 3) . The region was further narrowed down to a 1-6 kbp KpnI fragment and a 1-2 kbp HindIIIIKpnI fragment common to both virus strains. All three 2gtl 1 clones carried different sized inserts (400 to 500 bp in size) from this region of the genome and therefore represented independent cloning events. Examination of the nucleotide sequence in this region of the CMV (AD169) genome (Weston & Barrell, 1986 ) indicated one ORF (HWLF1) encoding a protein with an appropriate predicted size (66K) to correspond to the 76K ICP22 polypeptide. The 1.2 kbp HindlII/KpnI fragment, and thus the CH41-reactive epitope carried on the 2gtll clones, was entirely contained within the HWLF10RF, a reading frame first described as encoding a putative viral glycoprotein (two predicted N-linked glycosylation sites) that lacked a hydrophobic transmembrane region (Weston & Barrell, 1986) .
We detected two infected cell-specific transcripts, 2.4 and 4.8 kb in size, by RNA blot analysis of steady state RNA using pON293 as probe (Fig. 4) . These transcripts reached maximal steady state levels in infected cell RNA by 4 to 8 h p.i. even though synthesis rates of the ICP22 polypeptide peaked at 24 h p.i. No further increase in steady state transcript levels occurred at 48 or 72 h p.i. (data not shown). This early transcriptional activation but delay in full expression of protein is characteristic of other early and late CMV gene products (Geballe et al., 1986 a, b; Goins & Stinski, 1986) . The 4.8 kb transcript hybridized to a 2-2 kbp HindlII/BamHI fragment probe (pON2021) derived from sequences 5' of HWLF1, suggesting that the 2.4 kb transcript was more likely to encode ICP22. This result agreed with the observed positions of TATA and AATAAA signals surrounding HWLF1 (Weston & Barrell, 1986) . The larger transcript may have initiated at a TATA sequence adjacent to the HHLF5 ORF 5' to HWLF1 (Weston & Barrell, 1986) .
and a'c'-ca, denoted by thickened boxed areas and the unique sequences UL and Us denoted by a thin line. Genomic map units are indicated between this sequence arrangement and the restriction maps. Restriction maps for HindlII, EcoRI, XbaI, and BamHI for CMV (Towne) and (AD169) were from the literature (Fleckenstein et aL, 1982; La Femina & Hayward, 1980; Spector et al., 1982) and modified by our own comparisons (Kemble et al., 1987) . Restriction sites that are marked by a slash through the CMV (Towne) map correspond to those known to be common to both strains of virus. The A shown below the CMV (AD169) maps denotes an approx. 2 kbp deletion [relative to CMV (Towne) at this position (unpublished data)]. Restriction fragments shown to hybridize to the three CH41-reactive 2gt I 1 clones and the plasmid subclone, pON293, are denoted by thickened hatched lines. The expanded region below the genomic restriction maps encompasses the region of the ICP22 gene (HWLF1; Weston & Barrell, 1986) and includes the position of a 1.2 kbp KpnI/HindlII restriction fragment carrying the reactive epitope. All restriction sites shown in this region were deduced from the nucleotide sequence of CMV (AD169) (Weston & BarreU, 1986) . The putative ICP22 transcript (arrow) and plasmid clones pON293 and pON2021 are shown below the expanded region. By sequence analysis, HWLF1 appeared to have characteristics of a secretory protein, including predicted N-linked glycosylation sites and the absence of a hydrophobic transmembrane region. Our observations indicated diverse characteristics in the cellular localization of ICP22 depending on the particular technique employed; immunofluorescence showed nuclear localization, whereas cell fractionation showed cytoplasmic localization. We investigated whether ICP22 was released into the culture medium from infected cells at early (24 h) and late (120 h) times during infection. Consistent with many studies on other herpesvirus proteins that are exported from cells (Norrild & Vestergaard, 1979; Randall & Honess, 1980; Shiraki & Takahashi, 1982; Van Zaane et al., 1982; Reaet al., 1985; Patrick & Hinze, 1987) , [35S]methionine-labelled ICP22 could be immunoprecipitated from the cell free medium of infected cells at 72 h p.i. whereas other viral proteins (capsid, matrix and nonstructural proteins) could not be detected using appropriate monoclonal antibody reagents (data not shown). To determine more precisely whether soluble ICP22 was released from infected cells, CMV-infected or uninfected human fibroblast cells were radiolabelled with [3SS]methionine for 8 h periods at early (24 h p.i.) and late (120 h p.i.) times after which the cells and medium were collected. CMV-infected cells were viable and intact at both of these times. The culture medium was subjected first to a series of centrifugation steps (300 g, 3500 g, 12 000 g) to remove cell debris and virions (in the 120 h p.i. sample) followed by concentration and centrifugation at 100000 g to remove further debris (Fig. 5) . ICP22 which was readily detectable by immunoblot analysis with CH41 remained in the 100000 g supernatant in the 24 h p.i. sample and continued to accumulate until late times in infection. It should be noted that ICP22 was also associated with cell debris and virions and pelleted during the series of centrifugation steps (data not shown). Demonstration of ICP22 in the 100000g supernatant at 24 as well as 120hp.i. suggested release from infected cells. Although detection was not quantitative and significant Fig. 2 , were absent in the 100000 g supernatant. Consistent with previous results using late infected cell proteins (Pereira & Hoffman, 1986 ), a second CH41-reactive species with slightly lower electrophoretic mobility than the major species was observed in the 120 h p.i. whole cell sample. For preparation of supernatant proteins, medium was collected from [3sS]methionine pulse-labelled cells and L-l-tosylamide-2-phenylmethyl chloromethyl ketone (10p.M), leupeptin (2 ~tg/ml), sodium bisulphate (I0 raM), phenylmethylsulphonylttuoride (0.5 mM), dithiothreitol (1 mM), and glycerol (5 ~) were added. The following sequential pellets were collected (all work was at 4 °C): (i) cell debris by centrifugation at 2000 r.p.m, in a Beckman T J-6 centrifuge, (ii) cell debris and some virus by centrifugation at 5000 r.p.m, in a JA17 rotor in a Beckman J2-21 centrifuge, and (iii) virus by centrifugation in a microcentrifuge for 90 min. Following initial concentration, the supernatant was brought back to its original volume with 10 mM-potassium phosphate pH 7.5, 1 mM-EDTA, 50 mMNaC1, including leupeptin, sodium bisulphate, phenylmethylsulphonylfluoride, dithiothreitol, glycerol and L-l-tosylamide-2-phenylmethyl chloromethyl ketone as above, and reconcentrated. This supernatant was concentrated 100-fold using an Centricon 10 microconcentrator (Amicon) and subjected to centrifugation for 1.5 h at 100000g in a Beckman Airfuge.
amounts of ICP22 r e m a i n e d associated with cellular components a n d debris, it was consistent with the predicted characteristics of the H W L F 1 0 R F product (Weston & Barrell, 1986) . W e were initially attracted to study ICP22 because it was a relatively easily detected early protein that was localized to the nucleus of the infected cell. The nuclear pattern of immunofluorescence, the fractionation to the cytoplasm and the release of ICP22 from infected cells indicated more diverse functions of this protein. Nuclear localization by immunofluorescence but cytoplasmic localization by cell fractionation using non-ionic detergents might be due to either a perinuclear accumulation or to a detergent-extractable association with the nucleus. "he pattern of fluorescence that we detected at early or late times does not appear to be perinuclear. Because ICP22 was released at early times before viral maturation and release, its transport out of the cell does not appear to depend upon the viral maturation process. Sequence analysis of HWLF 1 suggested that release could occur by the vesicle transport pathway that has been well established for secretory proteins. Only further studies on the biological function of ICP22 can clarify the significance and mechanism of its cellular localization and release. The group of herpesvirus proteins that are released from infected cells is best illustrated by gX of PRV (Ben Porat & Kaplan, 1970; Pea er al., 1985) but ICP22 shares no detectable amino acid homology with gX or any other sequenced herpesvirus gene products. The function of such proteins in herpesvirus infections is unknown. ICP22 protein is encoded by an ORF that is a member of a family of related ORFs in the CMV genome that includes five related members in the S component, HWLF1, HHLF7, HHLF6, HHLF5 and HHLF1 and at least one member in the L component, HJLF4 (Kouzarides et al., 1988) , all of which lack putative transmembrane regions. The extensive amino acid homology of these ORFs may be the result of similar structural and/or functional requirements. Although several homologous families of proteins have been identified in the CMV genome, such groups are not a general characteristic of herpesvirus genomes. It is notable that monoclonal antibody CH41 recognizes the HWLF1 product but none of the other members of the family. We have not investigated the expression of the related ORFs.
ICP22 had been previously shown to be a highly immunogenic protein in humans and human monoclonal antibody 312.A.91.4 (Emanuel et al., 1984) has been shown to immunoprecipitate a protein with the same electrophoretic mobility as ICP22 (Pereira & Hoffman, 1986) . The identity of the 312.A.91.4-and CH41-reactive protein has been confirmed by first immunoprecipitating with 312. A. 91.4 and immunoblotting the electrophoretically separated immunoprecipitates with CH41 (unpublished data). Clearly, this protein is immunogenic in both humans and mice. The role of ICP22 as a target of the host immune response needs much more investigation. Likewise, the function of ICP22 in CMV infection needs to be assessed by constructing insertion or deletion mutants (Spaete & Mocarski, 1987) to disrupt the ICP22 gene in the viral genome.
